FS, M., W, F., A, V., C, D. F., N, B., E, G., . . . A, O. (2025). Comparative effectiveness and safety of tofacitinib and filgotinib in patients with ulcerative colitis: A propensity score-weighted cohort study. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 57(11), 2109. https://doi.org/10.1016/j.dld.2025.07.037
Chicago Style (17th ed.) CitationFS, Macaluso, et al. "Comparative Effectiveness and Safety of Tofacitinib and Filgotinib in Patients with Ulcerative Colitis: A Propensity Score-weighted Cohort Study." Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 57, no. 11 (2025): 2109. https://doi.org/10.1016/j.dld.2025.07.037.
MLA (9th ed.) CitationFS, Macaluso, et al. "Comparative Effectiveness and Safety of Tofacitinib and Filgotinib in Patients with Ulcerative Colitis: A Propensity Score-weighted Cohort Study." Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, vol. 57, no. 11, 2025, p. 2109, https://doi.org/10.1016/j.dld.2025.07.037.
